Zepp Health Statistics
Total Valuation
Zepp Health has a market cap or net worth of $486.53 million. The enterprise value is $537.09 million.
Important Dates
The last earnings date was Sunday, August 3, 2025, after market close.
| Earnings Date | Aug 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Zepp Health has 14.37 million shares outstanding. The number of shares has increased by 2.08% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 14.37M |
| Shares Change (YoY) | +2.08% |
| Shares Change (QoQ) | -1.12% |
| Owned by Insiders (%) | 36.36% |
| Owned by Institutions (%) | 15.50% |
| Float | 6.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.71 |
| Forward PS | n/a |
| PB Ratio | 2.38 |
| P/TBV Ratio | 2.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.10, with a Debt / Equity ratio of 0.47.
| Current Ratio | 1.10 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.61 |
Financial Efficiency
Return on equity (ROE) is -28.32% and return on invested capital (ROIC) is -7.40%.
| Return on Equity (ROE) | -28.32% |
| Return on Assets (ROA) | -5.10% |
| Return on Invested Capital (ROIC) | -7.40% |
| Return on Capital Employed (ROCE) | -15.28% |
| Revenue Per Employee | $261,369 |
| Profits Per Employee | -$101,448 |
| Employee Count | 765 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.65 |
Taxes
In the past 12 months, Zepp Health has paid $13.93 million in taxes.
| Income Tax | 13.93M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,045.47% in the last 52 weeks. The beta is 1.12, so Zepp Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | +1,045.47% |
| 50-Day Moving Average | 11.09 |
| 200-Day Moving Average | 4.92 |
| Relative Strength Index (RSI) | 82.42 |
| Average Volume (20 Days) | 536,231 |
Short Selling Information
| Short Interest | 332,415 |
| Short Previous Month | 8,091 |
| Short % of Shares Out | 5.51% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.26 |
Income Statement
In the last 12 months, Zepp Health had revenue of $199.95 million and -$77.61 million in losses. Loss per share was -$4.84.
| Revenue | 199.95M |
| Gross Profit | 75.03M |
| Operating Income | -45.95M |
| Pretax Income | -23.90M |
| Net Income | -77.61M |
| EBITDA | -42.27M |
| EBIT | -45.95M |
| Loss Per Share | -$4.84 |
Full Income StatementBalance Sheet
The company has $56.46 million in cash and $107.03 million in debt, giving a net cash position of -$50.57 million or -$3.52 per share.
| Cash & Cash Equivalents | 56.46M |
| Total Debt | 107.03M |
| Net Cash | -50.57M |
| Net Cash Per Share | -$3.52 |
| Equity (Book Value) | 225.39M |
| Book Value Per Share | 14.22 |
| Working Capital | 24.12M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 37.52%, with operating and profit margins of -22.98% and -38.81%.
| Gross Margin | 37.52% |
| Operating Margin | -22.98% |
| Pretax Margin | -31.87% |
| Profit Margin | -38.81% |
| EBITDA Margin | -21.14% |
| EBIT Margin | -22.98% |
| FCF Margin | n/a |
Dividends & Yields
Zepp Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.08% |
| Shareholder Yield | -2.08% |
| Earnings Yield | -15.95% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 16, 2024. It was a reverse split with a ratio of 1:4.
| Last Split Date | Sep 16, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
Zepp Health has an Altman Z-Score of 0.22 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.22 |
| Piotroski F-Score | 1 |